BusinessKura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate UpdateBy Nasdaq OMXMay 8, 2018, 8:05 PM UTC
BusinessExosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate®(IntelliScore) (EPI) TestBy Nasdaq OMXMay 8, 2018, 10:30 AM UTC
BusinessKura Oncology to Present at Deutsche Bank 43rd Annual Health Care ConferenceBy Nasdaq OMXMay 3, 2018, 11:30 AM UTC
BusinessKura Oncology Announces New Patent for Tipifarnib in Hematologic MalignanciesBy Nasdaq OMXMay 2, 2018, 11:31 AM UTC
BusinessWoman’s Hospital and Mary Bird Perkins – Our Lady of the Lake Cancer Center Open Breast and GYN Cancer PavilionBy Nasdaq OMXApr 30, 2018, 3:59 PM UTC
BusinessServier backs American startup’s research project at LabCentralBy Nasdaq OMXApr 26, 2018, 3:06 PM UTC
BusinessRadio Interview 12 Noon ET Today, April 26, 2018, With Cleartronic, Inc.’s CEO – Larry Reid; Discussion About Subsidiary VoiceInterop’s Signing a Definitive Agreement to Acquiring the Assets of CanniPlus Global, Inc.By Nasdaq OMXApr 26, 2018, 2:08 PM UTC
BusinessPrecipio Announces Participation Details for Upcoming Shareholder Conference CallBy Nasdaq OMXApr 26, 2018, 11:38 AM UTC
